InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,358.86
(
0.18%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: DewDiligence post# 207318

Sunday, 12/25/2016 5:08:00 PM

Sunday, December 25, 2016 5:08:00 PM

Post# of 252302
unfortunately one I wish was down from their IPO price and probably one of the only exceptions is BOLD. Its very thinly traded but is up from its $15 IPO price this summer.
http://www.streetinsider.com/IPOs/Audentes+Therapeutics+(BOLD)+IPO+Prices+at+$15,+Middle+of+Range/11845653.html

I've been following it for a while and seems its held up when other GT players have weakened (perhaps being so thin). Its still quite early so I'd like to see a bit more data especially at this price. Some of the preclinical data seemed compelling in 2 of their programs.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up